Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Contemporary Clinical Trials Communications
|
May 9, 2018
Study of the effectiveness of hippotherapy on the symptoms of multiple sclerosis - Outline of a randomised controlled multicentre study (MS-HIPPO)
Vanessa Wollenweber, Marion Drache, Sabine Schickendantz, et al.
Systematic Reviews
|
May 13, 2015
Assessing cost-effectiveness of HPV vaccines with decision analytic models: what are the distinct challenges of low- and middle-income countries? A protocol for a systematic review
Obinna I Ekwunife, Andreas Gerber Grote, Christoph Mosch, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 4, 2017
Hippotherapy for patients with multiple sclerosis: A multicenter randomized controlled trial (MS-HIPPO)
Vanessa Vermöhlen, Petra Schiller, Sabine Schickendantz, et al.
Pharmacoeconomics
|
September 18, 2016
Challenges in Cost-Effectiveness Analysis Modelling of HPV Vaccines in Low- and Middle-Income Countries: A Systematic Review and Practice Recommendations
Obinna I Ekwunife, James F O'Mahony, Andreas Gerber Grote, et al.
Pharmacoeconomics
|
October 9, 2015
Is There a European View on Health Economic Evaluations? Results from a Synopsis of Methodological Guidelines Used in the EUnetHTA Partner Countries
, Emelie Heintz, Andreas Gerber-Grote, et al.
Health Economics
|
March 5, 2014
Communicating the parameter uncertainty in the IQWiG efficiency frontier to decision-makers
Björn Stollenwerk, Stefan K Lhachimi, Andrew Briggs, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
February 6, 2016
Preferences for antiviral therapy of chronic hepatitis C: a discrete choice experiment
Axel C Mühlbacher, John F P Bridges, Susanne Bethge, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
November 10, 2015
Reporting health care decision models: a prospective reliability study of a multidimensional evaluation framework
Dirk Müller, Andreas Gerber-Grote, Björn Stollenwerk, et al.
MDM Policy & Practice
|
October 6, 2018
Estimation of Input Costs for a Markov Model in a German Health Economic Evaluation of Newer Antidepressants
Astrid Seidl, Marion Danner, Christoph J Wagner, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen
|
December 3, 2014
Decision making in Germany: is health economic evaluation as a supporting tool a sleeping beauty?
Andreas Gerber-Grote, Frank Gerd Sandmann, Min Zhou, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Contemporary Clinical Trials Communications
|
May 9, 2018
Study of the effectiveness of hippotherapy on the symptoms of multiple sclerosis - Outline of a randomised controlled multicentre study (MS-HIPPO)
Vanessa Wollenweber, Marion Drache, Sabine Schickendantz, et al.
Systematic Reviews
|
May 13, 2015
Assessing cost-effectiveness of HPV vaccines with decision analytic models: what are the distinct challenges of low- and middle-income countries? A protocol for a systematic review
Obinna I Ekwunife, Andreas Gerber Grote, Christoph Mosch, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 4, 2017
Hippotherapy for patients with multiple sclerosis: A multicenter randomized controlled trial (MS-HIPPO)
Vanessa Vermöhlen, Petra Schiller, Sabine Schickendantz, et al.
Pharmacoeconomics
|
September 18, 2016
Challenges in Cost-Effectiveness Analysis Modelling of HPV Vaccines in Low- and Middle-Income Countries: A Systematic Review and Practice Recommendations
Obinna I Ekwunife, James F O'Mahony, Andreas Gerber Grote, et al.
Pharmacoeconomics
|
October 9, 2015
Is There a European View on Health Economic Evaluations? Results from a Synopsis of Methodological Guidelines Used in the EUnetHTA Partner Countries
, Emelie Heintz, Andreas Gerber-Grote, et al.
Health Economics
|
March 5, 2014
Communicating the parameter uncertainty in the IQWiG efficiency frontier to decision-makers
Björn Stollenwerk, Stefan K Lhachimi, Andrew Briggs, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
February 6, 2016
Preferences for antiviral therapy of chronic hepatitis C: a discrete choice experiment
Axel C Mühlbacher, John F P Bridges, Susanne Bethge, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
November 10, 2015
Reporting health care decision models: a prospective reliability study of a multidimensional evaluation framework
Dirk Müller, Andreas Gerber-Grote, Björn Stollenwerk, et al.
MDM Policy & Practice
|
October 6, 2018
Estimation of Input Costs for a Markov Model in a German Health Economic Evaluation of Newer Antidepressants
Astrid Seidl, Marion Danner, Christoph J Wagner, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen
|
December 3, 2014
Decision making in Germany: is health economic evaluation as a supporting tool a sleeping beauty?
Andreas Gerber-Grote, Frank Gerd Sandmann, Min Zhou, et al.
Page
of 3